Class of Stock [Axis]
Series B Preferred Stock [Member]
Series C Preferred Stock [Member]
Series A Preferred Stock [Member]
Equity Components [Axis]
Preferred Stock Series B [Member]
Preferred Stock Series C [Member]
Contingently Redeemable Warrants [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Sale of Stock [Axis]
Private Placement [Member]
Warrants [Member]
QCLS Series H Convertible Preferred Stock [Member]
Transaction Type [Axis]
Femasys Purchase Agreement [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Femasys Note [Member]
Femasys Common Stock [Member]
Class of Warrant or Right [Axis]
Femasys Series B Warrants Expiration [Member]
Counterparty Name [Axis]
Femasys [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Securities Purchase Agreement [Member]
QCLS [Member]
Series G Preferred Stock [Member]
Long Term Warrant [Member]
Short Term Warrant [Member]
QCLS Series G Preferred Stock [Member]
Series G Warrants [Member]
QCLS Series H Warrant [Member]
QCLS Common Stock [Member]
QCLS Series H Preferred Stock [Member]
Measurement Input Type [Axis]
Measurement Input, Share Price [Member]
Measurement Input, Price Volatility [Member]
Measurement Input, Maturity [Member]
Measurement Redemption Premium [Member]
Measurement Input Market Interest Rate [Member]
Measurement Input, Risk Free Interest Rate [Member]
Measurement Input, Expected Dividend Rate [Member]
Measurement Input, Exercise Price [Member]
Measurement Input, Expected Term [Member]
QCLS Securities Purchase Agreement [Member]
Measurement Input Redemption Premium [Member]
QCLS Series H Warrants [Member]
Series H Preferred Stock [Member]
Investment Type [Axis]
Femasys Notes [Member]
Femasys Warrants [Member]
Femasys Series B Warrants [Member]
QCLS Series G Warrants [Member]
Location, Statement of Financial Position, Balance [Axis]
Nature of Expense [Axis]
Payroll Related Costs [Member]
Director Fees [Member]
R And D Costs [Member]
Legal Settlement [Member]
Excise Tax On Stock Repurchases [Member]
Plan Name [Axis]
2021 Equity Plan [Member]
2022 Equity Plan [Member]
Employees [Member]
Award Type [Axis]
Equity Option [Member]
Series B Warrants [Member]
Series B Preferred Warrants [Member]
Settlement Agreement [Member]
First Warrant Issuance [Member]
Additional Warrants [Member]
Settlement Warrants [Member]
Series C Private Placement Agreement [Member]
Series C Preferred Warrants [Member]
Series C Placement Agent Warrants [Member]
Employee Options [Member]
Warrant [Member]
Series B Warrants And Settlement Warrants Adjusted [Member]
Intangible Asset, Indefinite-Lived, Class [Axis]
Cytochrome P450 [Member]
Investment, Name [Axis]
SG Australia [Member]
Related and Nonrelated Parties [Axis]
Vin-de-Bona [Member]
SG Austria And Subsidiaries [Member]
Litigation Case [Axis]
H.C. Wainwright [Member]
Fair Value Of Warranty Liability [Member]
Gain On Related Party Investment Q C L S [Member]
Fair Value Of Derivative Liability [Member]
Issuance Costs On Convertible Preferred Stock And Warrants [Member]
Other [Member]
Expired Warrants [Member]
Redemption Of Note Receivable End Warrants [Member]
Forgone Benefit On Federal Tax N O Ls [Member]
Antidilutive Securities [Axis]
Excluded Options [Member]
Series C Convertible Preferred Stock [Member]
Preferred Shares [Member]
Accrued Dividends [Member]
Additional Cash Premium [Member]
Deemed Dividend [Member]
Preferred Dividend [Member]
Series C Purchase Agreement [Member]
Series C Warrants [Member]
Financial Instrument [Axis]
Derivative Liability [Member]
Treasury Stock, Common [Member]
May 2022 Repurchase Program [Member]
Restricted Stock Units (RSUs) [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 3 [Member]
Measurement Frequency [Axis]
Fair Value, Recurring [Member]
Warrant Liability [Member]
Bifurcated Embedded Derivative [Member]
Marketable Equity Securities [Member]
Fair Value, Inputs, Level 1 [Member]
Money Market Account [Member]
Convertible Note Receivable [Member]
Warrant asset - Femasys [Member]
Investment in preferred stock - QCLS [Member]
Warrant asset - QCLS [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Auditor Firm ID
Auditor Name
Auditor Location
Statement [Table]
Statement [Line Items]
ASSETS
Current assets:
Cash and cash equivalents
Marketable equity securities
Dividends receivable
Investment in preferred stock – QCLS - current
Warrant asset – QCLS - current
Convertible Note receivable – Femasys - current
Prepaid expenses and other current assets
Total current assets
Other assets:
Intangible assets
Investment in preferred stock – QCLS
Warrant assets – QCLS - non current
Warrant assets – Femasys
Other assets
Total other assets
Total Assets
LIABILITIES, TEMPORARY EQUITY AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued expenses
Accrued Series C dividends
Total current liabilities
Other liabilities:
Long-term portion of accrued expenses
Warrant liability
Derivative liability
Total other liabilities
Total Liabilities
Commitments and Contingencies (Note 9)
Temporary Equity:
Convertible preferred stock
Contingently redeemable warrants
Total temporary equity
Stockholders’ equity:
Preferred stock value
Common stock, authorized: 200,000,000 shares, $0.0001 par value; 26,005,715 and 21,672,095 shares issued and 10,735,649 and 6,795,779 shares outstanding as of April 30, 2026 and April 30, 2025, respectively.
Additional paid-in capital
Accumulated deficit
Treasury stock, at cost, 15,270,066 and 14,876,316 shares as of April 30, 2026, and 2025, respectively
Accumulated other comprehensive loss
Total stockholders’ equity
Total Liabilities, Temporary Equity and Stockholders’ Equity
Temporary equity, shares authorized
Temporary equity, par value
Temporary equity, face value
Temporary equity, shares issued
Temporary equity, shares outstanding
Temporary equity liquidation preference
Preferred stock, shares authorized
Preferred stock, par value
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, shares authorized
Common stock, par value
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, common shares
Income Statement [Abstract]
Revenue
Operating expenses:
Research and development costs
Intangible asset impairment
General and administrative
Total operating expenses
Loss from operations
Other income (expense):
Interest income
Dividend income
Change in fair value of warrant liability
Change in fair value of derivative liability
Change in fair value of convertible note receivable – Femasys
Change in fair value of warrant asset – Femasys
Change in fair value of investment – QCLS
Change in fair value of warrant assets – QCLS
Gain on related party investment – QCLS
Gain on legal settlement – re-fair value of warrants
Issuance costs – Series C convertible preferred stock and warrants
Unrealized gain (loss) on marketable securities
Loss on legal settlement
Loss on issuance of Series C preferred stock
Other expense, net
Total other income (expense), net
Income tax benefit (expense)
Net income (loss)
Preferred stock dividends
Undistributed income to Series B convertible preferred stock
Preferred stock accretion
Net income (loss) attributable to common stockholders
Basic income (loss) per share attributable to common stockholders
Diluted income (loss) per share attributable to common stockholders
Weighted average shares outstanding basic
Weighted average shares outstanding diluted
Net income (loss)
Other comprehensive income (loss):
Foreign currency translation adjustments
Other comprehensive income (loss)
Comprehensive income (loss)
Beginning balance, value
Beginning balance, shares
Fractional shares adjustment
Fractional shares adjustment, shares
Stock-based compensation options
Stock issued upon vesting of restricted stock units
Stock issued upon vesting of restricted stock units, shares
Stock issued for warrant exercises
Stock issued for warrant exercises, shares
Issuance of Series C preferred stock and warrants, net of transaction costs
Issuance of Series C preferred stock and warrants, net of transaction costs, shares
Preferred stock accretion
Series C preferred stock redeemed
Series C preferred stock redeemed, shares
Series C preferred stock subject to settlement
Series B preferred stock redemption
Series B preferred stock redemption, shares
Deemed dividend
Preferred stock dividends
Foreign currency translation adjustment
Net loss
Repurchase of common stock
Repurchase of common stock, shares
Ending balance, value
Ending balance, shares
Statement of Cash Flows [Abstract]
Cash flows from operating activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Gain on related party investment - QCLS
Issuance costs – Series C preferred stock and warrants
Loss on issuance of Series C preferred stock
Gain on re-fair value of warrants
Non-cash interest income
Non-cash warrant liability
Stock issued for compensation - RSUs
Stock-based compensation - options
Unrealized (gain) loss on marketable equity securities
Change in fair value of warrant liability
Change in fair value of derivative liability
Change in fair value of convertible note receivable - Femasys
Change in fair value of warrant assets - Femasys
Change in fair value of investment - QCLS
Change in fair value of warrants - QCLS
Change in assets and liabilities:
(Increase) decrease in prepaid expenses and other current assets
Increase (decrease) in accounts payable
Increase (decrease) in accrued expenses
Net cash used in operating activities
Cash flows from investing activities:
Investment in preferred stock and warrants - QCLS
Proceeds from investment – note receivable
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Repurchase of common stock, net
Net proceeds from issuance of Series C preferred stock
Redemption of preferred stock
Payment of Series C convertible preferred stock dividends
Net proceeds from warrant exercise
Net cash provided by (used in) financing activities
Effect of currency rate exchange on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of the year
Cash and cash equivalents at end of the year
Supplemental disclosure of cash flows information:
Cash paid during the year for income taxes
Supplemental schedule of non-cash investing and financing activities:
Accrual of Series C Convertible Preferred Stock dividends
Accretion of discounts to redemption value of Series C Preferred Stock
Initial fair value of investment in QCLS Series H preferred shares
Initial fair value of investment in QCLS Series H warrants
Non-cash derivative liability at initial fair value
Non-cash warrant liability at initial fair value
Non-cash conversion of Series C convertible stock
Change in fair value associated warrant exercises
Fair value of contingently redeemable placement agent warrants
Series B Convertible Preferred Stock dividends
Accretion of discounts to redemption value of Series B Convertible Preferred Stock
Excise tax accrued on repurchase of common stock
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Award Timing Disclosures [Line Items]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Cybersecurity Risk Management, Strategy, and Governance [Abstract]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management Processes Integrated [Flag]
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity Risk Management Third Party Engaged [Flag]
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
Cybersecurity Risk Role of Management [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible [Flag]
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]
Material Cybersecurity Incident [Abstract]
Material Cybersecurity Incident Nature [Text Block]
Material Cybersecurity Incident Scope [Text Block]
Material Cybersecurity Incident Timing [Text Block]
Material Cybersecurity Incident Material Impact or Reasonably Likely Material Impact [Text Block]
Material Cybersecurity Incident Information Not Available or Undetermined [Text Block]
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF BUSINESS
Liquidity And Other Uncertainties
LIQUIDITY AND OTHER UNCERTAINTIES
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of Investments [Abstract]
INVESTMENT IN DEBT AND EQUITY SECURITIES
Payables and Accruals [Abstract]
ACCRUED EXPENSES
Share-Based Payment Arrangement [Abstract]
STOCK OPTIONS AND WARRANTS
Intangible Asset, Goodwill and Other [Abstract]
INTANGIBLE ASSETS
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES
Income Tax Disclosure [Abstract]
INCOME TAXES
Earnings Per Share [Abstract]
EARNINGS PER SHARE
Equity [Abstract]
PREFERRED STOCK
TREASURY STOCK
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS
Principles of Consolidation and Basis of Presentation
Use of Estimates in the Preparation of Financial Statements
Cash and Cash Equivalents
Basic and Diluted Income (Loss) Per Share
Marketable Equity Securities
Investment in Q/C Technologies, Inc.
Intangible Assets
Convertible Note Receivable
Fair Value of Financial Instruments
Income Taxes
Research and Development
Stock-Based Compensation
Foreign Currency Translation
Derivative Financial Instruments
Warrants and Preferred Shares
Redeemable Preferred Stock
Segment Reporting
Recently Adopted Accounting Pronouncements
New Accounting Pronouncements Effective in Future Periods
Schedule of activity for the notes and warrants
Schedule of marketable equity securities
Schedule of activity for series H preferred stock and warrants
Schedule of accrued expenses
Schedule of assumptions for options
Schedule of stock option activity
Schedule of warrant activity
Schedule of intangible assets
Schedule of net pre-tax book income and/or loss
Schedule of effective income tax rate
Schedule of provision for income taxes
Schedule of deferred tax assets and liabilities
Schedule of basic and diluted earnings (loss) per share
Schedule of potentially dilutive securities
Schedule of fair value of financial liabilities
Schedule of change in the fair value warrant liability
Schedule of fair values of financial instruments by class
Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]
Subsidiary, Sale of Stock [Line Items]
Stock issued new, shares
Warrants issued
Proceeds from sale of equity
Investment shares
Payments for investment
Cash, uninsured amount
FDIC amount
Impairment of intangible assets
Number of operating segments
Number of reportable segments
Schedule of Investments [Table]
Schedule of Investments [Line Items]
Investment, beginning balance
Change in fair value
Settlement of note
Investment, ending balance
Warrants assets, beginning balance
Expiration of Series B Warrants
Change in fair value warrants
Warrants assets, ending balance
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Table]
Qualitative and Quantitative Information, Transferor's Continuing Involvement [Line Items]
Marketable equity securities, beginning balance
Interest paid in shares
Change in fair market value unrealized gain (loss)
Marketable equity securities, ending balance
DisclosureTable [Table]
DisclosureLineitem [Line Items]
Investment, beginnning balance
Purchased
Change in fair value
Investment, ending balance
Expiration of short-term warrants
Initial fair value of Investment
Change in fair value
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stockholders equity, reverse stock split
Investment shares owned
Payments for investments
[custom:ReceivableInstrumentConvertibleConversionPrice1-0]
Proceeds from investment - note receivable
Shares received for interest receivable
Interest receivable settled for stock
Interest and other income
Interest receivable
Change in fair value of convertible note receivable
Change in fair value of warrant asset
Convertible note receivable, current
Investment shares additions
Marketable securities
Unrealized gain loss on marketable securities
Warrant shares
Investment shares received
Accrued dividends receivable and dividend income
Recognized gain (loss)
Investment, fair value
Earnings Per Share, Basic
Earnings Per Share, Diluted
Net Income (Loss) Available to Common Stockholders, Basic
Exercise price
Fair value measurement
Investment, cost
Investment, fair value
Recognized gain (loss)
Fair value of the warrants
Accrued liabilities
Less: Long-term portion of legal settlement
Accrued liabilities, current
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate
Expected volatility
Expected lives (years)
Expected dividend yield
Number of options outstanding, beginning
Weighted average exercise price per share, beginning
Weighted average remaining contractual term
Number of options, granted
Weighted average exercise price per share, granted
Number of options, expired
Weighted average exercise price per share, expired
Number of options outstanding, ending
Weighted average exercise price per share, ending
Number of options, exercisable
Weighted average exercise price per share, exercisable
Weighted-average remaining contractual term, exercisable
Warrants outstanding, beginning balance
Weighted average exercise price warrants outstanding, beginning balance
Warrants issued
Weighted average exercise price warrants issued
Warrants exercised
Weighted average exercise price, warrants exercised
Warrants expired
Weighted average exercise price, warrants expired
Warrants outstanding, ending balance
Weighted average exercise price warrants outstanding, ending balance
Warrants exercisable
Weighted average exercise price warrants exercisable
Shares authorized for grant
Shares available for grant
Increase number of shares
Stock-based compensation
Employee service unrecognized compensation expense
Aggregate intrinsic value
RSU granted in period
RSU granted in period
Shares purchase
Shares purchase
Warrants acquire
Warrants exercised
Proceeds from warrant exercises
Warrants outstanding
Fair value of the warrants
Fair value per share
Gain on legal settlement
Issuance fair values
Change in fair value of warrant
Intangible Asset, Indefinite-Lived [Table]
Intangible Asset, Indefinite-Lived [Line Items]
Intangible asset
Intangible asset, impairment
Intangible assets net excluding goodwill
Related Party Transaction [Table]
Related Party Transaction [Line Items]
Equity interest
Consulting fees
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Research and development expenses
Rent expenses
Contractual obligation
Settlement amount
Initial payment
Periodic payment
Debt instrument periodic payment
Warrants issued shares
Warrants issued per share
Warrants issued, value
Share price
Dividend yield
Expected term
Equity volatility
Litigation settlement expense
Settlement payments
Accrued expenses
Accrued liabilities
United States
Foreign
Interim Period, Costs Not Allocable [Table]
Interim Period, Costs Not Allocable [Line Items]
Tax Jurisdiction of Domicile [Extensible Enumeration]
U.S. federal statutory tax rate, Amount
U.S. federal statutory tax rate, percentage
State income taxes, net of federal income tax effect, Amount
State income taxes, net of federal income tax effect, percentage
Foreign tax effects, Amount
Foreign tax effects, percentage
Changes in valuation allowances, Amount
Changes in valuation allowances, percentage
Non-taxable or non-deductible items
Non-taxable or non-deductible items, Amount
Non-taxable or non-deductible items, percentage
Other adjustments, Amount
Effective Income Tax Rate Reconciliation, Other Adjustments, Percent
Effective tax rate, Amount
Effective Income Tax Rate Reconciliation, Percent, Total
Federal benefit at statutory rate
State income taxes, net of Federal taxes
Fair value of warrant liability
Gain on related party investment
Fair value of derivative liability
Redemption of derivative liability
Expiration of warrant asset – Series B
State deferred tax adjustment
Legal settlement
Provision related to change in valuation allowance
Fair value of warrant asset – Series B
Expired stock options
Net valuation allowance for state NOLs
Other, net
Deferred tax assets:
Net operating loss carryforwards
Stock compensation
Research and development
Investment in SG Austria
Intangible asset (diabetes license)
Intangible asset (value of cells)
Fair value of investment in QCLS
Fair value of warrant asset
Other - deferred tax asset
Total deferred tax assets
Deferred tax liabilities:
Fair value of convertible note receivable
Fair value of warrant asset
Fair value of investment in QCLS
Other - deferred tax liability
Total deferred tax liabilities
Total deferred tax assets
Valuation allowance
Net deferred tax assets
Income tax expense for federal
Income tax expense for state
Income tax expense for foreign
Net operating loss carryforwards
Net operating loss carryforwards, federal
Net operating loss carryforwards, state
Change in valuation allowance
Accrued interest
Stock repurchased during the period
Payment for repurchase of common stock
Share repurchase program - excise tax
Earnings Per Share, Basic, by Common Class, Including Two-Class Method [Table]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Less: Accretion of discounts to redemption of convertible preferred stock
Less: Convertible preferred stock dividends
Less: Allocation of undistributed income to convertible preferred stock
Undistributed income (loss) available to common stockholders
Weighted average shares outstanding used in basic earnings per share
Net income (loss) per share basic
Net income (loss) per share diluted
Antidilutive Security, Excluded EPS Calculation [Table]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares
Stock, Class of Stock [Table]
Class of Stock [Line Items]
Preferred Stock, Shares Authorized
Temporary Equity, Par or Stated Value Per Share
[custom:PreferredStockSharesDesignated-0]
Temporary Equity, Shares Outstanding
[custom:ExcludedSubjectToRedemptionValue-0]
Preferred stock accretion
Change in fair value of the derivative liability
Fair value of embedded derivative
Redemptions paid in cash
Dividends, Preferred Stock
Aggregate shares
Preferred stock, par value
Preferred stock, stated value
Conversion shares
Conversion price
Aggregate gross proceeds
Placement agent, cash fee percentage
Transaction costs
Derivative Assets (Liabilities), at Fair Value, Net
Derivative, measurement input
Total discount on preferred stock
Fair value of embedded derivative
Fair value of warrant
Proceeds from issuance of preferred stock
Deemed dividend
Change in fair value derivative liability
Preferred dividends
Dividend paid in cash
Dividend accrued
Stock converted
Shares issued
Number of shares authorized
Number of shares repurchased
Number of shares repurchased, value
Number of shares redeemed
Number of shares redeemed, value
Stock repurchase program, remaining amount
Restricted stock
Shares purchase, value
Treasury stock, shares
Treasury stock, value
Fair Value, off-Balance-Sheet Risk [Table]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Fair value of financial liability
Fair Value, Recurring and Nonrecurring [Table]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of the warrant liability at beginning
Issuance of warrants
Exercise of warrants
Fair value of the warrant liability at ending
Bifurcated embedded derivative liability at beginning
Issuance of convertible preferred stock with bifurcated embedded derivative liability
Change in fair value of bifurcated embedded derivative
Bifurcated embedded derivative liability at ending
Fair value of financial assets
QCLS Series H Convertible Preferred Stock [Member]
Femasys Purchase Agreement [Member]
Femasys Note [Member]
Femasys [Member]
Femasys Common Stock [Member]
Femasys Notes [Member]
Femasys Warrants [Member]
Femasys Series B Warrants [Member]
Securities Purchase Agreement [Member]
QCLS [Member]
Long Term Warrant [Member]
Short Term Warrant [Member]
QCLS Series G Preferred Stock [Member]
Series G Warrants [Member]
QCLS Series G Warrants [Member]
QCLS Series H Warrant [Member]
QCLS Common Stock [Member]
QCLS Series H Preferred Stock [Member]
Measurement Redemption Premium [Member]
Measurement Input Market Interest Rate [Member]
QCLS Securities Purchase Agreement [Member]
Measurement Input Redemption Premium [Member]
QCLS Series H Warrants [Member]
Payroll Related Costs [Member]
Director Fees [Member]
R And D Costs [Member]
Legal Settlement [Member]
Excise Tax On Stock Repurchases [Member]
2021 Equity Plan [Member]
2022 Equity Plan [Member]
Employee Options [Member]
Employees [Member]
Series B Warrants [Member]
Series B Preferred Warrants [Member]
Settlement Agreement [Member]
First Warrant Issuance [Member]
Additional Warrants [Member]
Settlement Warrants [Member]
Series C Private Placement Agreement [Member]
Series C Preferred Warrants [Member]
Series C Placement Agent Warrants [Member]
Series B Warrants And Settlement Warrants Adjusted [Member]
Excluded Options [Member]
Warrants [Member]
Series C Convertible Preferred Stock [Member]
Cash Premium [Member]
Preferred Shares [Member]
Accrued Dividends [Member]
Deemed Dividend [Member]
Preferred Dividend [Member]
Series C Purchase Agreement [Member]
Derivative Liability [Member]
May 2022 Repurchase Program [Member]
Warrant Liability [Member]
Bifurcated Embedded Derivative [Member]
Marketable Equity Securities [Member]
Money Market Account [Member]
Convertible Note Receivable [Member]
Investment in preferred stock - QCLS [Member]
Warrant asset - Femasys [Member]
Warrant asset - QCLS [Member]
Cytochrome P450 [Member]
SG Australia [Member]
Vin-de-Bona [Member]
SG Austria And Subsidiaries [Member]
H.C. Wainwright [Member]
Income Tax Jurisdiction, Domestic Federal [Member]
Assets, Current
Assets, Noncurrent
Assets
Liabilities, Current
Other Liabilities
Liabilities
TotalTemporaryEquity
Equity, Attributable to Parent
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
UndistributedIncomeToSeriesBConvertiblePreferredStock
Preferred Stock, Accretion of Redemption Discount
Net Income (Loss) Available to Common Stockholders, Basic
Other Comprehensive Income (Loss), Net of Tax
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Shares, Outstanding
DeemedDividends
Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings
LossOnIssuanceOfSeriesCPreferredStock
GainOnFairValueOfWarrants
NoncashInterestIncome
ChangeInFairValueOfInvestmentQcls
ChangeInFairValueOfWarrantsQcls
Increase (Decrease) in Prepaid Expense and Other Assets
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
InvestmentInPreferredStockAndWarrantsInQcls
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Payments for Repurchase of Common Stock
RedemptionOfPreferredStock
PaymentOfSeriesCConvertiblePreferredStockDividends
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Marketable Securities
Investments and Other Noncurrent Assets
Realized Investment Gains (Losses)
Accrued Professional Fees
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
WarrantExercised
WarrantsExpired
Stock Issued During Period, Value, Restricted Stock Award, Gross
Other Accrued Liabilities
Accrued Liabilities and Other Liabilities
Effective Income Tax Rate Reconciliation, Percent
Deferred Tax Assets, Gross
DeferredTaxLiabilitiesConvertibleNoteReceivable
Deferred Tax Liabilities, Derivatives
DeferredTaxLiabilitiesFairValueOfInvestmentInQCLS
Deferred Tax Liabilities, Other
Deferred Tax Liabilities, Gross
Deferred Tax Assets, Net of Valuation Allowance
Deferred Tax Assets, Valuation Allowance
Deferred Tax Assets, Net
Operating Loss Carryforwards
Redeemable Preferred Stock Dividends
PreferredStockParValuePerShare
FairValueEmbeddedDerivative
Embedded Derivative, Fair Value of Embedded Derivative Liability